Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harte-Hanks

4.52
+0.16003.67%
Post-market: 4.40-0.1200-2.65%16:01 EDT
Volume:26.35K
Turnover:118.68K
Market Cap:33.26M
PE:-1.10
High:5.08
Open:4.42
Low:4.33
Close:4.36
Loading ...

HHS, FDA announce set of actions and initiatives focused on infant formula

TIPRANKS
·
13 hours ago

Harte Hanks Q4 Revenue USD 47.129 Million

THOMSON REUTERS
·
17 Mar

Harte Hanks Reports Fourth Quarter and Fiscal 2024 Full-Year Results

ACCESS Newswire
·
17 Mar

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

Quartz
·
14 Mar

President Trump and Medicare: 3 Things You Should Know

Motley Fool
·
13 Mar

Market Chatter: PepsiCo, General Mills Among Food Brands Set to Meet With HHS Secretary

MT Newswires Live
·
10 Mar

Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan

ACCESS Newswire
·
04 Mar

HHS increasing scrutiny of vaccines under RFK Jr., WSJ reports

TIPRANKS
·
04 Mar

GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy

NewMediaWire
·
03 Mar

Doximity and Krispy Kreme have been highlighted as Zacks Bull and Bear of the Day

Zacks
·
28 Feb

Bear of the Day: Krispy Kreme (DNUT)

Zacks
·
28 Feb

Moderna Shares Fall After Reports of HHS Review of Bird Flu Vaccine Contract -- WSJ

Dow Jones
·
28 Feb

Moderna's stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award

Dow Jones
·
28 Feb

Moderna Shares Fall on Report HHS Is Reviewing Bird Flu Vaccine Contract -- Barrons.com

Dow Jones
·
27 Feb

Court Dismisses Novartis Challenge To Medicare Drug Price Negotiation Program

Benzinga
·
27 Feb

OraSure Reports Fourth Quarter 2024 Financial Results

GlobeNewswire
·
26 Feb